Pediatrics and Human Development researcher André Bachmann has been awarded an ADVANCE Grant in the amount of $80,000 for his study of TIR-199 as a potential proteasome inhibitor. The ADVANCE Fund is administered by Michigan State University and the Michigan Strategic Fund through the Michigan Economic Development Corporation, and is intended to incentivize public faculty with early-stage technologies to advance their research. Please join us in congratulating Dr. Bachmann and wishing him great success in yet another fascinating endeavor.